OVERVIEW

Cirrus' proven approach to contract drug product development moves our clients' compounds through the development process quickly and efficiently. Resources exist to develop a broad range of traditional dosage forms (e.g., injectable, oral and topical products), as well as novel drug delivery systems (e.g., inhalation, intranasal or novel protein delivery). Cirrus offers extensive expertise in the development of aerosol products, including Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), nasal sprays and solutions for nebulization.

The team-oriented environment at Cirrus provides responsive, reliable, and integrated services for research, product development, and laboratory testing. To focus on our core strengths, we build collaborative partnerships with qualified subcontractors to offer an extensive menu of services.

Whether for full-scale product development or release testing of a marketed product, Cirrus can meet the requirements.